Bax is a proapoptotic protein that is required for programmed cell death (PCD) of many neuronal populations. Here we show that, during an early period of retinal PCD and in naturally occurring sensory and motor neuron (MN) death in the spinal cord, Bax delivery results in enhanced death of these neural populations. In contrast, Bax overexpression fails to enhance an early phase of MN death that occurs in the cervical spinal cord, although overexpressed Bax appears to be activated in dying MNs. Bax overexpression does not also affect the survival of immature neurons prior to the PCD period. Taken together, these data provide the first in vivo evidence suggesting that Bax appears to act selectively as an executioner only in neurons undergoing PCD. Furthermore, although Bax appears to mediate the execution pathway for PCD, the effect of Bax overexpression on susceptibility to death differs between different neuronal populations.
Introduction
The Bcl-2 family of proteins are known to regulate the survival and death of various types of cells including neurons. 1 Individual family members can act to either prevent or promote programmed cell death (PCD). 1 Bax, a proapoptotic member of the Bcl-2 family, is widely expressed in the nervous system during development 2, 3 and is required for neuronal death since Bax deficiency has been demonstrated to prevent developmental and induced neuronal death. 2, [4] [5] [6] Although the necessity of Bax for normal PCD of many neuronal populations during development is well recognized, several questions remain concerning the specific role of Bax in neuronal survival and death in vivo.
In vitro studies have shown that Bax exists in an inactive form when cells are not exposed to apoptotic stimuli but then undergoes translocation and /or conformational changes in response to apoptotic stimuli, which leads to cell death. [7] [8] [9] Cultured sympathetic neurons abundantly express Bax, but nonetheless survive unless trophic factors are removed from the culture medium. 2 These data indicate that Bax appears to act as an executioner only in cells exposed to death stimuli. On the other hand, the intracellular balance between anti-versus proapoptotic Bcl-2 family members is important in determining whether cells survive or die. 3, 6, 10 The balance can be changed in favor of proapoptosis in several pathological conditions which cause neuronal damage. [11] [12] [13] It has been previously reported that overexpression of Bax induces death of cultured neurons in the absence of obvious apoptotic stimuli. 3 Therefore, the relative levels of Bax expression may in itself be important for regulating cell death in developing neuron even in the absence of extracellular proapoptotic signals.
To address how the post-translational activation of Bax and the levels of Bax expression are involved in survival and death of developing neurons in vivo, we examined the effects of Bax overexpression on different neuronal populations in the chicken embryo. To introduce exogenous Bax into neuronal populations in vivo, we employed two distinct methods, constitutive expression by a noncytopathic avian retroviral vector and inducible expression by in ovo electroporation coupled with tet regulation. We chose to investigate several different types of normal neuronal PCD, including an early phase of retinal PCD, naturally occurring spinal sensory and motor neuron (MN) death, and an early novel type of MN death in the cervical region. In all these neuronal populations, Bax appears to be activated and acts as a proapoptotic molecule selectively in dying neurons during the normal PCD period. However, whereas Bax overexpression enhances PCD in most populations examined, there was no apparent effect on the early phase of cervical MN PCD. These data reveal an inherent difference in developing neuronal populations in vivo in their susceptibility to undergo apoptosis following Bax overexpression.
interaction, since TVB receptors, identified as cellular receptors for the cytopathic subgroup B and D viruses, appear to be a tumor necrosis factor receptor-related death receptor with a cytoplasmic death domain. 14 Although we did not detect cytopathic effects of RCASBP viruses with the B subgroup envelope, 15 to avoid possible extrinsic death signaling by viral Env-receptor interaction, we employed the noncytopathic subgroup A virus RCASBP(A) for Bax delivery (Figure 1a) .
The DF-1 chick fibroblast cell line was known to allow infection and propagation of RCAS viruses efficiently. 16, 17 A few DF-1 cells appeared to undergo PCD 24 h after the conventional transfection procedure of viral constructs expressing human Bax (hBax). Following several passages, however, DF-1 cells expressing hBax or its fusion protein with enhanced green fluorescent protein (EGFP) could be cultured normally in growth medium although hBax or EGFP-Bax were abundantly expressed in DF-1 cells (Figure 1b) . DF-1 cells did not undergo PCD after infection of RCASBP(A)Bax, suggesting that viral infection is less toxic to cells than plasmid transfection. We also observed dying cells in Bax-transfected cells compared with wild-type or EGFP-transfected cells soon after subculturing procedure. Thus, we assume that Bax overexpression does not affect cell viability unless the cells are stressed. To further examine the effect of Bax expression on DF-1 cells under normal growth conditions, we counted the number of cells following infection of viruses. There were no significant differences in the number of DF-1 cells at any time point between any of the groups examined (Figure 1c ). These results indicate that retroviral-mediated Bax overexpression does not alter cell growth, nor does it promote cell death under normal growth conditions.
Bax promotes PCD of DF-1 cells when exposed to death stimuli
We next examined whether Bax overexpression affects the survival of DF-1 cells exposed to apoptotic stimuli known to induce cell death through Bax-dependent mechanisms. 18 DF-1 cells expressing Bax or EGFP-Bax underwent cell death more rapidly than control cells when deprived of serum (Figure 1d ). When exposed to a kinase inhibitor (staurosporine (STS)), cell death was also induced more efficiently in these Bax-transfected cells than in control cells ( Figure 1e ). As expected, DF-1 cells expressing Bcl-2 were resistant to STS-induced death (Figure 1e ), indicating that expression levels of exogenous genes using this vector are sufficient to act in DF-1 cells.
We then investigated whether foreign Bax is activated in serum-deprived DF-1 cells by using immunocytochemistry. Although Bax immunoreactivity was not clear in healthy cells overexpressing Bax, cells overexpressing EGFP-Bax primarily exhibited a faint, diffuse pattern if cells were healthy (see Figure S1 in the Supplementary material). After 24 h of serum deprivation, apparent dying cells containing condensed or fragmented nuclei were observed. These cells displayed both an intense, punctate Bax distribution pattern and a diffuse, cytosolic pattern of cytochrome c staining. Caspase-3 is also activated in these cells. In contrast, apparent non-dying cells that exhibited intact nuclei and a punctate, mitochondrial cytochrome c staining pattern displayed a diffuse Bax staining pattern (see Figure S1 in the Supplementary material). Thus, hBax appears to act in avian cells through its redistribution from a diffuse pattern to a punctate pattern, followed by subsequent activation of caspase-3.
Bax enhances early PCD of developing immature retinal neurons
The developing chick retina undergoes at least two distinct periods of PCD. 19 The earlier period of PCD between embryonic day (E) 5 and 7 involves proliferating and migrating immature neurons. In this early phase of PCD, TUNELlabeled cells appeared to be increased in the neural retina of Bax-transfected embryos compared to both controls and EGFP-transfected embryos (Figure 2a-d, j) . Activated capase-3 immunoreactivity was also increased in the Bax-transfected retina and its location was identical to the region where a punctate staining pattern of Bax is observed (Figure 2e-h ). Infection of RCASBP(A)EGFP-Bax revealed that many dying cells are restricted to the retinal region corresponding to the virus-infected area (Figure 2i ), suggesting that enhanced PCD is due to Bax overexpression in the neural retina versus in other tissues.
To study the effects of Bax overexpression in the neural retina before the early phase of PCD, we examined the eye cup at E3. At this stage dying cells in the retina were almost exclusively in the optic disc region (Cuadros and Rios 20 and Figure 2k ). Bax overexpression appeared to enhance PCD only in the optic disc region, but did not induce PCD in other areas of the retina although the virus vector was expressed widely over the entire neural retina (Figure 2l, m) . These results indicate that Bax selectively enhances the death of only those early retinal cell subpopulations which are actively undergoing normal PCD.
Bax enhances naturally occurring neuronal death in the spinal cord
To further clarify the action of Bax in vivo, we next examined a type of PCD in the spinal cord that involves postmitotic, differentiating cells that have established synaptic connections with target cells and which is regulated by trophic signals. 21 In this common and well-studied type of PCD, Bax has been shown to be required for the death of both the dorsal root ganglia (DRG) neurons and MNs. 4, 5, 22 In control embryos, a small number of TUNEL-labeled cells were detected in both the DRG (Figure 3a ) and the ventral horn (VH) (Figure 3d ) at E6 when PCD of early differentiating sensory and MNs is occurring. 21 In contrast to control embryos, considerably larger numbers of TUNEL-labeled cells were observed in both Bax-transfected DRG neurons (Figure 3b We next examined immature neurons before the period of normal PCD. 21 Few, if any, TUNEL-labeled cells in either the DRG or VH were observed in either control or Bax-transfected embryos on E3 prior to the normal period of PCD in the developing spinal cord (see Figure S2 in the Supplementary material). In contrast, TUNEL-labeled cells appeared to be increased by Bax overexpression in the dorsal region of the spinal cord where cells, including the neural crest, are located that undergo normal PCD at this stage of development (ref. 24 and see Figure S2 in the Supplementary material).
We also examined whether Bax overexpression affected the target cells of DRG neurons such as developing skin and the dorsal horn of the spinal cord. Although the Bax vector was expressed in both the spinal cord and skin (see Figure S3 in the Supplementary material), the number of TUNEL-labeled cells in these regions were similar in control and Baxtransfected embryos (see Figure S3 in the Supplementary material). The muscle targets of MNs also appear to develop similarly in control and Bax-transfected embryos (data not shown). Thus, the enhanced PCD of sensory and MNs is not likely due to target cell perturbation, but rather to the direct action of hBax in sensory and MNs. Taken together, these data indicate that Bax overxpression does not induce the death of cells in neuronal populations in vivo which do not undergo normal PCD, but rather only increases the death of neuronal populations that are in the process of normal developmental PCD.
Cells that would normally survive the period of PCD undergo apoptosis following Bax overexpression
To determine whether enhanced PCD observed in Baxtransfected embryos represents an acceleration versus an increase in the overall magnitude of PCD, cell numbers were counted after the period of PCD. In the retinal ganglion cell layer at E9, there was a 10-20% increased loss of cells in the 
Bax fails to enhance early MN death in the cervical spinal cord
In addition to the typical target-dependent naturally occurring MN death observed at relatively late stages (E6-10) of spinal cord development, another type of MN death occurs only in the cervical region of the spinal cord between E4 and E5. 25 At E4.5 when this early PCD occurs in the VH of the cervical spinal cord, there is no significant difference in the number of TUNEL-labeled cells in control versus Bax-transfected embryos (Figure 5a ). By contrast, Bcl-2 overexpression with this same vector clearly reduces the number of TUNELlabeled cells (Figure 5a ). Moreover, Bax delivery into lumbar MNs clearly shows an increase of TUNEL-labeled cells during the later PCD period (Figure 3f) . Thus, the absence of increased PCD in the cervical MNs on E4.5 of Bax-transfected embryos is not likely due to an insufficient level of Bax expression (Figure 5a ).
To examine whether Bax overexpression results in death of immature cervical MNs prior to the onset of normal PCD on E4.5, we counted the number of MNs at E4. There were no significant differences in the number of MNs between any of the groups examined (Figure 5b ). This indicates that Bax overexpression neither induces cell death in young MNs nor affects the number of MNs generated prior to the onset of PCD. The number of MNs in Bax-transfected embryos after the period of cervical MN death was also comparable to control embryos (Figure 5c ). Therefore, we conclude that, in contrast to retinal cells, DRG cells, and lumbar MNs, retroviral-mediated Bax overexpression does not alter early PCD of MNs in the cervical spinal cord of the chicken embryo.
We next asked whether Bax immunoreactivity occurs in dying MNs. Consistent with cell counts, similar number of MNs exhibited fragmented nuclei and caspase-3 activation in the VH of the cervical spinal cord of control and Bax-transfected embryos (Figure 5d,e,h,i) . In contrast to control embryos, however, many cells in the VH of the Bax-transfected embryos exhibit a punctate Bax staining pattern as was observed in the retina, the DRG, and lumbar MNs at later developmental stages (Figure 5f , j). Most of these cells also contained either fragmented nuclei or caspase-3 activation, suggesting that hBax is, in fact, activated in dying cervical MNs (Figure 5k ). When EGFP-Bax is delivered into cervical MNs, many cells show a diffuse distribution of EGFP-Bax (Figure 5l, m) , although a few MNs exhibit a punctate pattern, together with fragmented nuclei or caspase-3 activation (Figure 5l, n) . Thus, hBax appears to be activated selectively in dying MNs.
Inducible expression of gain-of-function Bax mutants, but not naive Bax, enhances the early cervical MN death
Although retroviral-mediated Bax delivery clearly enhances the death of lumbar MNs, the level of Bax expression in spinal MNs is generally lower than in the retina or the DRG ( Figures  2i, 3o) ; moreover, the RCASBP retroviral vector induces global transgene expression in the chick (see Figure S2 in the Supplementary material). Accordingly, to introduce Bax specifically into MNs during the period of early PCD, we have used in ovo electroporation 26 coupled with the tet regulatory system. 23 To target gene expression to spinal MNs, the reverse tetracycline-controlled transactivator is expressed under the control of the MN-specific HB9 promoter. 27 We successfully controlled GFP expression spatially and temporally in MNs by administration of doxycycline (see Figure S4 in the supplementary material).
When EGFP-Bax was introduced into cervical MNs by this method, the ratio of healthy MN to dying MN was similar to that from control embryos transfected with GFP alone (Figure 6a,  b, d ). These data are consistent with those described above using the viral delivery model. Thus, it seems likely that the lack of enhanced PCD is not due to low levels of Bax expression in cervical MNs. We also generated Bax mutants, S184A and dS184, which are derived from mutation of Ser184 and appear to function as gain-of-function mutants. 8 These EGFP-Bax mutants significantly increased the ratio of dying MNs compared with GFP and EGFP-Bax (Figure 6a, c, e) . Both EGFP-Bax and the mutants display a punctate cellular pattern with caspase-3 activation in dying MNs (Figure 6f, g ). These results suggest that foreign naive Bax is not active in those cervical MNs that would normally survive the early PCD To clear MN population in which hBax is activated, we next examined the expression of LIM homeodomain transcription factors that define different types of MNs. 28 We focused on LIM homeodomain genes Lim-3, because dying population appears to be a subgroup of MN that lacks the expression of Lim-3 (Yaginuma et al., unpublished). Prior to the onset of PCD (E4), both Lim-3-positive and -negative MNs showed a diffuse distribution of EGFP-Bax (Figure 7a, b) , suggesting that inactive hBax is introduced into both populations. During the PCD period (E4.5), Lim-3-positive MNs displayed a diffuse Most MNs showing a diffuse localization of EGFP-Bax are not associated with caspase-3 activation (arrow heads), whereas a small population displaying a punctuate Bax pattern also exhibit caspase-3 activation (arrow; a higher magnification image is shown in n). Scale bar in m, 30 mm. Scale bar in n, 10 mm distribution of EGFP-Bax with intact nuclei (Figure 7c, d) . By contrast, MNs exhibiting a punctate pattern of hBax lacked Lim-3 immunoreactivity (Figure 7e, f) . At E4.5 we checked six embryos (at least 15 cervical sections per embryo) and failed to find Lim-3-positive MNs with a punctate pattern of hBax and fragmented nuclei. Thus, Bax activation appears to occur in cervical MNs that lack the expression of Lim-3.
Discussion
Bax is known to be inactive when cells are not exposed to apoptotic stimuli, but then undergoes translocation and/or conformational changes in response to apoptotic stimuli, which results in the release of mitochondrial proteins (such as cytochrome c) and leads to cell death. [7] [8] [9] 18 Previous studies have shown that cells overexpressing Bax proliferate normally 29 and undergo PCD after death stimuli by conformational changes of Bax, resulting in its translocation to mitochondria. 7 Moreover, sympathetic neurons express high levels of bax mRNA, yet will not undergo PCD unless deprived In contrast, a Lim-3-negative MN (arrow heads) exhibits a fragmented nucleus (e) with a punctate pattern of Bax (f). Scale bar, 10 mm of growth factors. 2 Other studies pointed out that the expression of Bax increases during PCD, as well as under pathological conditions. 3, 6, [10] [11] [12] [13] In the present studies, we initially examined the effects of Bax overexpression on several different neuronal populations that undergo normal PCD. These include the early phase of developing retinal PCD which appears to be induced by death signaling through NGF and TGF-b, 30, 31 as well as the common type of neuronal PCD that occurs in developing sensory and MNs of the spinal cord after forming synaptic connections with targets. 32 In these populations, Bax enhanced normal PCD, but by contrast did not cause the death of cells in populations prior to the onset of normal PCD. Dying neurons, but not healthy neurons, displayed a punctate Bax distribution pattern accompanied by caspase-3 activation. Our results are consistent with previous in vitro studies showing that Bax is a potent proapoptotic molecule for developing neurons undergoing PCD, and provide the first in vivo evidence that Bax is inactive in developing neurons that are not undergoing PCD. Thus, although increased expression of Bax may also be a factor for PCD, apoptotic signaling appears to be required for Bax activation in vivo and post-translational activation of Bax is essential for neurons to die.
It has long been known that a significant proportion of cells in many neuronal populations undergo PCD during development, whereas other neurons in the same population can survive throughout development and into adulthood. 32 In vertebrates, it has been recognized that extrinsic signals derived from cell-cell interactions, such as target-derived trophic signals, are critically involved in regulating how many neurons in an apparently homogenous population survive or die. In the present study, especially in the DRG, the cellular sources of extrinsic trophic signals appeared to be largely unaffected by Bax overexpression, since the main source of trophic factors (target tissues), including the skin and the dorsal spinal cord, were not perturbed (see Figure S3 in the Supplementary material). If sufficient amounts of extrinsic trophic signals completely define the number of surviving neurons, then it would be expected that Bax overexpression would primarily accelerate the death of the sub-population of neurons destined to die. However, a proportion of neurons that would normally survive also underwent PCD following Bax overexpression (Figure 4) . Thus, in these neuronal populations, susceptibility to death can be changed by the levels of Bax expression. Based on the observation that active death signaling is required for Bax to act as a proapoptotic molecule, such signaling is likely to be transmitted to both neurons fated to die as well as to those that would normally survive (Figure 8 ). Interestingly, although virtually all neurons were infected with a Bax vector (Figures 2c, 3o) , a majority of neurons can still survive the period of PCD (Figure 4) . Collectively, these data suggest that individual neurons in a population may not be homogeneous, but rather may differ in their vulnerability to undergo PCD by virtue of differences in their intracellular machinery and/or environment. Previous studies suggested that a balance between anti-versus proapoptotic Bcl-2 family members determine the susceptibility of cells to die. 3, 6, 10 Other cellular factors such as heat shock protein (HSP) 27 may be involved in regulating survival and death of neurons. 33 Thus, whether a neuron lives or dies during the period of developmental PCD may be regulated by both extrinsic (e.g., neurotrophic factors) and intrinsic (e.g. Bcl-2 members, HSP27, etc) signals. It has long been recognized that the later PCD of MNs in the spinal cord occurring between E6 and E10 is regulated by target-derived signals. 32 By contrast, the earlier phase of MN death (E4-E5) occurs independent of target-derived trophic signals. 25 Recent studies demonstrated that this early MN Figure 8 Summary of Bax action in developing neuronal populations in vivo. During early retinal PCD and the period of naturally occurring death of DRG and MNs, the decision to die or survive is regulated by extrinsic factors. Bax overexpression does not affect these neurons prior to the PCD period, but enhances death through activation of Bax during the PCD period. In contrast, Bax overexpression does not affect the survival of spinal MNs in the cervical region either prior to or during the early PCD period, although Bax appears to be activated in dying cervical MNs. These findings suggest that death signaling is required for the effects of Bax on these neurons in vivo. The mechanism for the decision to die or survive in cervical spinal MN during this early phase of PCD is currently unclear. But intrinsic factors (e.g. Lim-3) may be involved in the process death is accompanied by caspase-3 activation and can be prevented by Bcl-2, suggesting that both early and later MN death may involve a similar execution pathway. 15, [34] [35] [36] However, in the present study, we found that Bax overexpression does not enhance this early cervical MN death, even though hBax appears to be activated in dying MNs which exhibit caspase-3 activation. These results suggest that the lack of an enhancement of PCD in cervical MNs by Bax overexpression is not likely due to a distinct execution pathway that is independent of Bax. Rather, putative death signals may affect only a restricted subpopulation of cervical MNs, whereas other MNs in the same population fail to undergo Bax activation (even though Bax is substantially expressed) because of the lack of death signals ( Figure 8 ).
Gain-of-function mutants of Bax clearly enhanced the death of early cervical MNs ( Figure 6 ). Since these constitutively active mutants also result in caspase-3 activation, the downstream execution pathway following Bax activation appears to be conserved in the subpopulation of MNs that would normally survive the early PCD period. As a previous study suggested that this PCD is controlled independent of peripheral targets, the fate of individual MNs in the cervical spinal cord may be intrinsically determined. 25 We recently found that dying population appears to be a subgroup of MN that lacks the expression of LIM homeodomain genes Lim-3, and introduction of this transcription factor rescues cervical MN from early PCD (Yaginuma et al., unpublished) . Present data show that Bax is inactive in Lim-3-positive MNs (Figure 7 ). Collectively, although overexpression studies must always be interpreted cautiously, our data suggest that death signals that mediate Bax activation appear to be transmitted to a limited population (Lim-3-negative MNs). By contrast, in other populations examined (e.g., retina, DRG, lumbar MNs), death-inducing signals may be widely transmitted to all or most neurons in the population. Although these differences may be the basis for the distinct susceptibility to die following Bax overexpression among cells in different neuronal populations, further in vivo studies examining the selective deletion or inactivation of Bax in these different populations are needed to more definitively test this idea.
Materials and Methods

Constructs and virus generation
To generate retroviral plasmids carrying Bax, the hBax cDNA was initially cloned into the adaptor plasmid Slax13Nco, and subsequently cloned into the RCASBP(A) retroviral plasmid. 37 For the GFP-fusion constract, Bax was initially cloned into the C2-EGFP plasmid (Clontech). Then, the EGFPBax fragment was cloned into the Slax13Nco plasmid, and finally cloned into the RCASBP(A) plasmid. High-titer viruses were generated by standard procedures with only minor modification. 15, 23 Briefly, virus propagation was initiated by transfection of retroviral plasmid constructs into the DF-1 chick fibroblast cell line. 16, 17 After several passages of DF-1 cells, the supernatants were collected and concentrated by centrifugation at 22 000 rpm for 3 h in a Beckman SW 28 rotor and stored in aliquots at À801C. Typical virus titers were 1-5 Â 10 8 cfu/ml. The reverse tetracycline-controlled transactivator was placed into the AscI/XbaI site on a HB9 plasmid. Bax mutants were generated by standard PCR. The following primers were used in the PCR: introducing an XhoI site for the N-terminus, 5 0 -ttaattcctcgagcatggacgggtccggggagca-3 0 ; an EcoRI site for the C-terminus of the dS184 mutant, 5 0 -gcgtcagaa ttctcagcccatcttcttccagatggtgagggcggtgagcac-3 0 ; and the S184A mutant 5 0 -gcgtcagaattctcagcccatcttcttccagatggtgagcgcggcggtgagcac-3 0 . These mutants were cloned into the pEGFP-C2 vector. Then, EGFP, EGFP-Bax, EGFP-Bax(dS184), and EGFP-Bax(S184A) were cloned into the pTRETight vector (Clontech).
Cell culture, immunoblotting, and cell growth assay DF-1 cells were cultured in DMEM high-glucose medium (Gibco) containing 10% fetal bovine serum (FBS, Sigma). DF-1 cells were infected with each of the viruses at 50 infectious units per cell. After a few passages of the DF-1 cells, immunoblotting was performed as described previously, 23 using the polyclonal anti-Bax antibody N-20 (Santa Cruz). For cell growth assays, cells were initially plated at a density of 6 Â 10 3 cells/well in 12-well tissue culture plates (Greiner). After 1 day later, cells were infected with each of the viruses at 50 infectious units/cell. Cell counts were performed every 24 h following viral infection. The MannWhitney test was used for statistics unless otherwise noted.
Cell viability assay
Transfected cells were plated in four-well petri dishes (Greiner) and cultured in DMEM containing 10% FBS for 1 day. After being washed with PBS, growth medium was replaced with serum-free medium. The number of surviving cells in each well was counted for a week. The number of surviving cells immediately after serum deprivation was considered as the 100% value. Alternatively, transfected cells were plated at a density of either 5 Â 10 3 or 2.5 Â 10 3 per well in 96-well tissue culture plates. After being cultured in growth medium for 1 day, cells were washed with PBS and cultured in either serum-free medium or medium supplemented with 1% FBS and 0.5-1 mM STS for 24 h. Supernatants were collected from each well and lactate dehydrogenase activity was measured as described by the manufacturer (Roche).
Chicken embryo, virus infection, and in ovo electroporation
White Leghorn chicken eggs were purchased from Takeuchi poultry farm (Nara, Japan) and incubated at 37.61C in a humidified incubator. Early embryos were staged according to Hamburger and Hamilton. 38 Viruses were injected into embryos at stage 9 (E1.5) via a pulled micropipette needle as described. 15, 23 Typically, a total of 0.2-0.5 ml of virus solution was injected into a lumen of the neural tube.
Plasmids were injected into a lumen of stage 13-14 (E2-2.5) chick spinal cords. Electroporation was performed using a square wave electroporator (CUY21EDIT) as described elsewhere.
26 Doxycycline (10 mg; Sigma) was added at 24 and again at 36 h after electroporation, and embryos were harvested at 48 h (E4.5) after electroporation.
Immunohistochemistry, cell death assay, and quantification of neuron numbers Immunohistochemistry was performed as described previously. 15, 23, 34 Primary antibodies used in this study were the anti-Islet-1/2 (clone 4D5, Developmental Studies Hybridoma Bank, DSHB), anti-Lim-3 (clone 67.4E12, DSHB), antiviral p19 GAG protein (clone AMV-3C2, DSHB), antiactivated caspase-3 (clone C92-605, Pharmingen), and anti-Bax (clone 4F11, MBL). We tested three distinct antibodies for hBax from either Santa Cruz (polyclonal antibody, N-20), MBL (monoclonal antibody, 4F11), or Pharmingen (polyclonal antibody). All these antibodies specifically recognized hBax in tissue sections and appeared to fail to react with endogenous chicken Bax. As sections reacted with 4F11 antibody displayed lower background staining, we used 4F11 antibody to detect foreign Bax in the tissue sections. Dying cells were observed by either TUNEL staining or detection of activated caspase-3, as described previously. 15 DRG neurons were counted in every fifth section through the third lumber segment (L3) using hematoxylin-eosin-stained sections as described previously. 21 Retinal ganglion cells were counted in five different microscope fields at Â 1000 magnification in the naso-central region of horizontal sections of the retina, which contains the optic nerve. Lumbar (L) MNs were counted in every fifth section through the L1-L4 segments using thionin-stained sections as described previously. 21 To quantify MN numbers per spinal cord section, Islet-1/2 immunoreactive neurons in the VH were counted in every fifth section through the C10-11 cervical segment with segment boundaries identified relative to adjacent DRGs.
